"head and neck cancer squamous cell carcinoma" trang 5 - tải miễn phí từ tailieunhanh
Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma

Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma
10    112    0
Tongue carcinoma infrequently harbor common actionable genetic alterations

Tongue carcinoma infrequently harbor common actionable genetic alterations
9    42    1
Head and neck cancer risk factors in the French West Indies

Head and neck cancer risk factors in the French West Indies
9    29    1
Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma
13    31    1
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma

Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma
10    44    1
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study

Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study
6    1    1
Metastatic squamous cell carcinoma from primary hypopharynx source to gastric mucosa presenting as massive gastrointestinal bleeding

Metastatic squamous cell carcinoma from primary hypopharynx source to gastric mucosa presenting as massive gastrointestinal bleeding
5    6    2
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors – a central role for STAT3

Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors – a central role for STAT3
13    44    1
Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma

Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma
9    70    0
Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner

Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner
14    28    1
A pilot study to profile salivary angiogenic factors to detect head and neck cancers

A pilot study to profile salivary angiogenic factors to detect head and neck cancers
8    84    0
Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC
11    26    1
Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer

Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer
7    68    1
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients

Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
10    27    1
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
10    88    0
EGFR modulates complement activation in head and neck squamous cell carcinoma

EGFR modulates complement activation in head and neck squamous cell carcinoma
12    70    0
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
11    70    1
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): Study protocol for a randomized phase II trial

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): Study protocol for a randomized phase II trial
13    75    1
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
19    39    1
L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: A retrospective cohort study

L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: A retrospective cohort study
9    37    1